Get started
Author

Balram Chowbay

Observed names: B Chowbay, B. Chowbay, Balram Chowbay (110465), Chowbay Balram, Chowbay, B, Chowbay, Balram
Observed institutions: Agency for Science, Technology and Research, SingHealth, Sun Yat-sen University, Queensland University of Technology, National University of Singapore, Nanyang Technological University, Singapore General Hospital, Singapore Immunology Network, Erasmus MC, National Cancer Center, Institute of Cancer Research, SingHealth Duke-NUS Academic Medical Centre, National University Cancer Institute, Singapore, Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Duke-NUS Medical School, National Cancer Centre Singapore, National Cancer Institute, National University Hospital, National University Health System, Temple University
ORCID: 0000-0003-4775-9877
Observed ORCID: 0000-0003-4775-9877
OpenAlex ID: A5019107660
Polymorphism of human cytochrome P450 enzymes and its clinical impact
2009 · Shu-Feng Zhou, Jun-Ping Liu, et al. · Drug Metabolism Reviews · 826
A common BIM deletion polymorphism mediates intrinsic resistance and inferior responses to tyrosine kinase inhibitors in cancer
2012 · King Pan Ng, Axel M Hillmer, et al. · Nature Medicine · 556
Herbal Modulation of P‐Glycoprotein
2004 · Shufeng Zhou, Lee Yong Lim, et al. · Drug Metabolism Reviews · 375
Genetic polymorphisms in MDR1 and CYP3A4 genes in Asians and the influence of MDR1 haplotypes on cyclosporin disposition in heart transplant recipients
2003 · Balram Chowbay, Sivathasan Cumaraswamy, et al. · Pharmacogenetics · 250
Tamoxifen metabolism predicts drug concentrations and outcome in premenopausal patients with early breast cancer
2014 · P Saladores, T Mürdter, et al. · The Pharmacogenomics Journal · 199
PDF
Long noncoding RNA EGFR-AS1 mediates epidermal growth factor receptor addiction and modulates treatment response in squamous cell carcinoma
2017 · Daniel S W Tan, Fui Teen Chong, et al. · Nature Medicine · 165
Genetic association study of exfoliation syndrome identifies a protective rare variant at LOXL1 and five new susceptibility loci
2017 · Tin Aung, Mineo Ozaki, et al. · Nature Genetics · 155
Phase I pharmacokinetic study of a weekly liposomal paclitaxel formulation (Genexol®-PM) in patients with solid tumors
2009 · W.T. Lim, E.H. Tan, et al. · Annals of Oncology · 141
Influence of ABCB1 and ABCG2 polymorphisms on doxorubicin disposition in Asian breast cancer patients
2008 · Suman Lal, Zee Wan Wong, et al. · Cancer Science · 134
PDF
Pharmacogenetics of Target Genes Across Doxorubicin Disposition Pathway: A Review
2010 · Suman Lal, Anupama Mahajan, et al. · Current Drug Metabolism · 131
A common variant mapping to CACNA1A is associated with susceptibility to exfoliation syndrome
2015 · Blue Mountains Eye Study GWAS Team, Tin Aung, et al. · Nature Genetics · 126
Impact of CYP2D6, CYP3A5, CYP2C9 and CYP2C19 polymorphisms on tamoxifen pharmacokinetics in Asian breast cancer patients
2011 · Joanne S. L. Lim, Xiang A. Chen, et al. · British Journal of Clinical Pharmacology · 122
PDF
Role of UGT1A1*6, UGT1A1*28 and ABCG2 c.421C>A polymorphisms in irinotecan‐induced neutropenia in Asian cancer patients
2007 · Srinivasa Rao Jada, Robert Lim, et al. · Cancer Science · 122
PDF
A Phase II Study of Pazopanib in Asian Patients with Recurrent/Metastatic Nasopharyngeal Carcinoma
2011 · Wan-Teck Lim, Quan-Sing Ng, et al. · Clinical Cancer Research · 121
An Interethnic Comparison of Polymorphisms of the Genes Encoding Drug-Metabolizing Enzymes and Drug Transporters: Experience in Singapore
2005 · Balram Chowbay, Shufeng Zhou, et al. · Drug Metabolism Reviews · 120
Meta‐analysis of the influence of MDR1 C3435T polymorphism on digoxin pharmacokinetics and MDR1 gene expression
2005 · Balram Chowbay, Huihua Li, et al. · British Journal of Clinical Pharmacology · 119
Extracellular vesicle drug occupancy enables real-time monitoring of targeted cancer therapy
2021 · Sijun Pan, Yan Zhang, et al. · Nature Nanotechnology · 105
Genetic risk of extranodal natural killer T-cell lymphoma: a genome-wide association study
2016 · Zheng Li, Yi Xia, et al. · The Lancet Oncology · 95
Pharmacogenetic profiling across the irinotecan pathway in Asian patients with cancer
2005 · Qingyu Zhou, Alex Sparreboom, et al. · British Journal of Clinical Pharmacology · 94
PDF
Pharmacogenetics of SLCO1B1 gene and the impact of *1b and *15 haplotypes on irinotecan disposition in Asian cancer patients
2006 · Xiaoqiang Xiang, Srinivasa Rao Jada, et al. · Pharmacogenetics and Genomics · 93
Novel SLC22A16 Polymorphisms and Influence on Doxorubicin Pharmacokinetics in Asian Breast Cancer Patients
2007 · Suman Lal, Zee Wan Wong, et al. · Pharmacogenomics · 91
Transport of Cryptotanshinone, a Major Active Triterpenoid in Salvia Miltiorrhiza Bunge Widely Used in the Treatment of Stroke and Alzheimers Disease, Across the Blood-Brain Barrier
2007 · Xi-Yong Yu, Shu-Guang Lin, et al. · Current Drug Metabolism · 89
CBR1andCBR3pharmacogenetics and their influence on doxorubicin disposition in Asian breast cancer patients
2008 · Suman Lal, Edwin Sandanaraj, et al. · Cancer Science · 80
Pan-Cancer Analysis of Ligand–Receptor Cross-talk in the Tumor Microenvironment
2021 · Umesh Ghoshdastider, Neha Rohatgi, et al. · Cancer Research · 78
PDF
Docetaxel is effective in heavily pretreated patients with disseminated nasopharyngeal carcinoma
2010 · J. Ngeow, W.T. Lim, et al. · Annals of Oncology · 77
Works count: 178
Citation count: 6,586
H-index: 42
I10-index: 79
Year
Topic
Type